Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency.
Year: 1997
Type: article
Abstract: To evaluate the role of tumor necrosis factor (TNF alpha) in bone loss resulting from estrogen deficiency, the effects of ovariectomy were explored in six-month-old transgenic mice expressing high blood levels of a soluble TNF receptor type I (sTNFR1)-FcIgG3 fusion protein, which neutralizes TNF alpha, and in their nontransgenic littermates used as controls. These transgenic mice were identical to control mice in bone mass (evaluated by bone mineral density and content) and strength. 12 weeks after ovariectomy, the decrease in bone mass and increase in osteocalcin (marker of bone turnover) found in control mice were not observed in transgenic mice, which were not different from sham-operated mice, transgenic or not. This observation suggests a critical role for TNF alpha in the pathogenesis of bone loss induced by estrogen deficiency, a common cause of morbidity in postmenopausal women.
DOI: 10.1172/jci119333
Language: English
Topic: Bone Metabolism and Diseases
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Awards: A.Role of TNF in infection and chronic diseases B.Role of bcl-2 and bcl-X variants in programmed neuronal cell death, Prevention of osteoporosis, Immune response and inflammation. Apoptosis, cancer and meta- stasis, Marie-Heim Vögtlin Beitrag : Studies on the role of TNF and bcl-2 related genes by the use of transgenic mice, chimaeric mice and microinjection of fibroblasts and neurons.
OpenAlex ID: W1986714785
